Nanosonics has been growing earnings at an average annual rate of 22.3%, while the Medical Equipment industry saw earnings growing at 13.6% annually. Revenues have been growing at an average rate of 15.1% per year. Nanosonics's return on equity is 9.4%, and it has net margins of 9.9%.
Key information
22.29%
Earnings growth rate
22.09%
EPS growth rate
Medical Equipment Industry Growth
8.90%
Revenue growth rate
15.09%
Return on equity
9.36%
Net Margin
9.92%
Last Earnings Update
31 Dec 2025
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Nanosonics makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
OTCPK:NNCS.F Revenue, expenses and earnings (AUD Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
31 Dec 25
207
21
108
34
30 Sep 25
203
21
106
34
30 Jun 25
199
21
104
35
31 Mar 25
191
19
101
34
31 Dec 24
184
17
98
33
30 Sep 24
177
15
96
33
30 Jun 24
170
13
93
33
31 Mar 24
167
14
91
32
31 Dec 23
164
16
88
32
30 Sep 23
165
18
87
31
30 Jun 23
166
20
85
29
31 Mar 23
154
15
81
27
31 Dec 22
141
10
77
25
30 Sep 22
131
7
73
24
30 Jun 22
120
4
68
22
31 Mar 22
120
7
64
21
31 Dec 21
121
11
60
20
30 Sep 21
112
10
57
19
30 Jun 21
103
9
54
17
31 Mar 21
99
7
51
17
31 Dec 20
95
6
49
16
30 Sep 20
97
8
48
16
30 Jun 20
100
10
48
16
31 Mar 20
96
11
47
14
31 Dec 19
92
12
46
13
30 Sep 19
88
13
42
12
30 Jun 19
84
14
38
11
31 Mar 19
78
12
36
11
31 Dec 18
71
11
34
11
30 Sep 18
66
8
33
10
30 Jun 18
61
6
33
10
31 Mar 18
61
6
31
10
31 Dec 17
61
6
29
10
30 Sep 17
64
16
28
10
30 Jun 17
68
26
28
9
31 Mar 17
65
26
26
9
31 Dec 16
63
25
25
8
30 Sep 16
53
13
25
8
30 Jun 16
43
0
25
7
31 Mar 16
33
-5
25
7
31 Dec 15
23
-10
24
6
30 Sep 15
23
-8
21
5
30 Jun 15
22
-5
18
5
Quality Earnings: NNCS.F has high quality earnings.
Growing Profit Margin: NNCS.F's current net profit margins (9.9%) are higher than last year (9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NNCS.F's earnings have grown significantly by 22.3% per year over the past 5 years.
Accelerating Growth: NNCS.F's earnings growth over the past year (24.1%) exceeds its 5-year average (22.3% per year).
Earnings vs Industry: NNCS.F earnings growth over the past year (24.1%) exceeded the Medical Equipment industry 14.8%.
Return on Equity
High ROE: NNCS.F's Return on Equity (9.4%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/05/25 11:16
End of Day Share Price
2026/05/15 00:00
Earnings
2025/12/31
Annual Earnings
2025/06/30
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Nanosonics Limited is covered by 14 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.